| Schedule of Computation of the Company’s Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders |
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders for the three-month period ended March 31, 2026:
|
|
|
Three Months
Ended
March 31,
2026
|
|
Three Months
Ended
March 31,
2025
|
|
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(17,812,415 |
)
|
|
$
|
(7,467,201 |
)
|
|
Weighted average common shares outstanding
|
|
|
241,039,943 |
|
|
|
159,272,518 |
|
|
Basic earnings per share
|
|
$
|
(0.07 |
)
|
|
$
|
(0.05 |
)
|
|
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(17,812,415 |
)
|
|
$
|
(7,467,201 |
)
|
|
Weighted-average common shares outstanding
|
|
|
241,039,943 |
|
|
|
159,272,518 |
|
|
Dilutive effect of common share equivalents
|
|
|
—
|
|
|
|
—
|
|
|
Weighted-average common shares outstanding, assuming dilution
|
|
|
241,039,943 |
|
|
|
159,272,518 |
|
|
Diluted earnings per share
|
|
$
|
(0.07 |
)
|
|
$
|
(0.07 |
)
|
|
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders for the year ended December 31, 2025:
|
|
|
Year Ended
December 31,
2025
|
|
Basic earnings per share:
|
|
|
|
|
Net income (loss)
|
|
$
|
74,004,768 |
|
Weighted-average common shares outstanding
|
|
|
142,298,067 |
|
Basic earnings per share
|
|
$
|
0.52 |
|
Diluted earnings per share:
|
|
|
|
|
Net income (loss)
|
|
$
|
74,004,768 |
|
Weighted-average common shares outstanding
|
|
|
142,298,067 |
|
Dilutive effect of common share equivalents
|
|
|
—
|
|
Weighted-average common shares outstanding, assuming dilution
|
|
|
142,298,067 |
|
Diluted earnings per share
|
|
$
|
0.52 |
|
| Schedule of Potential Common Shares Outstanding that were Excluded From the Computation of Diluted Net Earnings Per Share of Common Stock |
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net earnings per share of common stock as of the periods presented because including them would have been anti-dilutive:
|
|
|
Three Months
Ended
March 31,
2026
|
|
Three Months
Ended
March 31,
2025
|
|
Common stock warrants
|
|
17,900,000 |
|
—
|
|
RSUs issued and outstanding to contractors
|
|
846,844 |
|
—
|
|
RSUs issued and outstanding to employees
|
|
7,483,060 |
|
—
|
|
Total potential common shares excluded from diluted net earnings per share
|
|
26,229,904 |
|
—
|
|
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net earnings per share of common stock as of the periods presented because including them would have been anti-dilutive:
|
|
|
Year Ended
December 31,
2025
|
|
Common stock warrants
|
|
17,900,000 |
|
RSUs issued and outstanding
|
|
5,984,957 |
|
Total potential common shares excluded from diluted net earnings per share
|
|
23,884,957 |
|